Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 1Breast Diseases 1

Interventions

Paclitaxel 164Fulvestrant 158Trastuzumab 157pembrolizumab 146Letrozole 136Carboplatin 120pertuzumab 105Capecitabine 105Cyclophosphamide 103Specimen Handling 101Anastrozole 91palbociclib 86abemaciclib 83Magnetic Resonance Spectroscopy 80exemestane 77Docetaxel 76ribociclib 74Tamoxifen 74trastuzumab deruxtecan 67Radiotherapy 62Biopsy 58Surveys and Questionnaires 55olaparib 53Gemcitabine 53130-nm albumin-bound paclitaxel 53sacituzumab govitecan 51Blood Specimen Collection 50Taxes 49Standard of Care 49eribulin 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Blood Pressure × Breast × 1 year × Clear all
NCT05006196 2026-05-20

IMOGEN

Perspectum

Active not recruiting
1,030 enrolled
Breast

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡